CX3CR1	0	6	B-Gene_or_gene_product
-	6	7	O
dependent	7	16	O
subretinal	17	27	B-Cell
microglia	28	37	I-Cell
cell	38	42	I-Cell
accumulation	43	55	O
is	56	58	O
associated	59	69	O
with	70	74	O
cardinal	75	83	O
features	84	92	O
of	93	95	O
age	96	99	O
-	99	100	O
related	100	107	O
macular	108	115	B-Tissue
degeneration	116	128	O
.	128	129	O

The	131	134	O
role	135	139	O
of	140	142	O
retinal	143	150	O
microglial	151	161	B-Cell
cells	162	167	I-Cell
(	168	169	O
MCs	169	172	B-Cell
)	172	173	O
in	174	176	O
age	177	180	O
-	180	181	O
related	181	188	O
macular	189	196	B-Tissue
degeneration	197	209	O
(	210	211	O
AMD	211	214	O
)	214	215	O
is	216	218	O
unclear	219	226	O
.	226	227	O

Here	228	232	O
we	233	235	O
demonstrated	236	248	O
that	249	253	O
all	254	257	O
retinal	258	265	B-Cell
MCs	266	269	I-Cell
express	270	277	O
CX3C	278	282	B-Gene_or_gene_product
chemokine	283	292	I-Gene_or_gene_product
receptor	293	301	I-Gene_or_gene_product
1	302	303	I-Gene_or_gene_product
(	304	305	O
CX3CR1	305	311	B-Gene_or_gene_product
)	311	312	O
and	313	316	O
that	317	321	O
homozygosity	322	334	O
for	335	338	O
the	339	342	O
CX3CR1	343	349	B-Gene_or_gene_product
M280	350	354	O
allele	355	361	O
,	361	362	O
which	363	368	O
is	369	371	O
associated	372	382	O
with	383	387	O
impaired	388	396	O
cell	397	401	B-Cell
migration	402	411	O
,	411	412	O
increases	413	422	O
the	423	426	O
risk	427	431	O
of	432	434	O
AMD	435	438	O
.	438	439	O

In	440	442	O
humans	443	449	B-Organism
with	450	454	O
AMD	455	458	O
,	458	459	O
MCs	460	463	B-Cell
accumulated	464	475	O
in	476	478	O
the	479	482	O
subretinal	483	493	B-Immaterial_anatomical_entity
space	494	499	I-Immaterial_anatomical_entity
at	500	502	O
sites	503	508	O
of	509	511	O
retinal	512	519	B-Multi-tissue_structure
degeneration	520	532	O
and	533	536	O
choroidal	537	546	O
neovascularization	547	565	O
(	566	567	O
CNV	567	570	O
)	570	571	O
.	571	572	O

In	573	575	O
CX3CR1	576	582	B-Gene_or_gene_product
-	582	583	O
deficient	583	592	O
mice	593	597	B-Organism
,	597	598	O
MCs	599	602	B-Cell
accumulated	603	614	O
subretinally	615	627	B-Immaterial_anatomical_entity
with	628	632	O
age	633	636	O
and	637	640	O
albino	641	647	O
background	648	658	O
and	659	662	O
after	663	668	O
laser	669	674	O
impact	675	681	O
preceding	682	691	O
retinal	692	699	B-Multi-tissue_structure
degeneration	700	712	O
.	712	713	O

Raising	714	721	O
the	722	725	O
albino	726	732	O
mice	733	737	B-Organism
in	738	740	O
the	741	744	O
dark	745	749	O
prevented	750	759	O
both	760	764	O
events	765	771	O
.	771	772	O

The	773	776	O
appearance	777	787	O
of	788	790	O
lipid	791	796	B-Drug_or_compound
-	796	797	O
bloated	797	804	O
subretinal	805	815	B-Cell
MCs	816	819	I-Cell
was	820	823	O
drusen	824	830	B-Pathological_formation
-	830	831	O
like	831	835	O
on	836	838	O
funduscopy	839	849	O
of	850	852	O
senescent	853	862	O
mice	863	867	B-Organism
,	867	868	O
and	869	872	O
CX3CR1	873	879	B-Gene_or_gene_product
-	879	880	O
dependent	880	889	O
MC	890	892	B-Cell
accumulation	893	905	O
was	906	909	O
associated	910	920	O
with	921	925	O
an	926	928	O
exacerbation	929	941	O
of	942	944	O
experimental	945	957	O
CNV	958	961	O
.	961	962	O

These	963	968	O
results	969	976	O
show	977	981	O
that	982	986	O
CX3CR1	987	993	B-Gene_or_gene_product
-	993	994	O
dependent	994	1003	O
accumulation	1004	1016	O
of	1017	1019	O
subretinal	1020	1030	B-Cell
MCs	1031	1034	I-Cell
evokes	1035	1041	O
cardinal	1042	1050	O
features	1051	1059	O
of	1060	1062	O
AMD	1063	1066	O
.	1066	1067	O

These	1068	1073	O
findings	1074	1082	O
reveal	1083	1089	O
what	1090	1094	O
we	1095	1097	O
believe	1098	1105	O
to	1106	1108	O
be	1109	1111	O
a	1112	1113	O
novel	1114	1119	O
pathogenic	1120	1130	O
process	1131	1138	O
with	1139	1143	O
important	1144	1153	O
implications	1154	1166	O
for	1167	1170	O
the	1171	1174	O
development	1175	1186	O
of	1187	1189	O
new	1190	1193	O
therapies	1194	1203	O
for	1204	1207	O
AMD	1208	1211	O
.	1211	1212	O

